MedTrace Logo

Nutritional Requirements for Vitamin D in Pregnant Women

NCT02506439 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2024-11-19

No results posted yet for this study

Summary

Randomised, placebo-controlled dose-response intervention study with vitamin D3 in pregnant women.

Conditions

  • Vitamin D Deficiency

Interventions

DIETARY_SUPPLEMENT

10 mcg Vitamin D3

Once daily, 10mcg (400IU) dose of vitamin D3 taken from baseline visit (approx 15 weeks gestation) until endpoint (delivery)

DIETARY_SUPPLEMENT

20 mcg Vitamin D3

Once daily, 20mcg (800IU) dose of vitamin D3 taken from baseline visit (approx 15 weeks gestation) until endpoint (delivery)

DIETARY_SUPPLEMENT

Placebo

Once daily, placebo capsule containing 0mcg (0IU) of vitamin D3 taken from baseline visit (approx 15 weeks gestation) until endpoint (delivery)

Sponsors & Collaborators

Principal Investigators

  • Mairead Kiely, PhD · University College Cork

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-01
Primary Completion
2017-04-01
Completion
2017-04-01

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02506439 on ClinicalTrials.gov